VANIQA® reduces unwanted facial hair in women
VANIQA® is a prescription cream clinically proven to reduce the growth of unwanted facial hair in women. VANIQA® works in the hair follicle during the growth stage of the hair cycle, interfering with an enzyme necessary for hair to grow.
Improvement may be seen as early as 4-8 weeks of treatment. Individual results may vary.
Read the rebate offer terms and conditions.
Please note that according to federal and state laws this offer is not available to patients enrolled in Medicare, Medicaid, or any other government health program.
To receive your rebate and special offers, please fill out the information below.
Be sure to add VANIQA.com to your email safe senders list.
This will ensure delivery of your savings voucher.
A note about privacy:
Your answers to the survey questions, along with the answers of other individuals, may be shared in an anonymous fashion with other third parties or government agencies for research purposes.
You are responsible for reporting delivery of a rebate to any private insurer that pays for, or reimburses you for, any part of the prescription filled.
Duplicates will not be accepted. See rebate certificate for expiration date.
Offer not valid for prescriptions reimbursed or paid under Medicare, Medicaid, or any similar federal or state healthcare program including any state medical or pharmaceutical assistance programs. Offer void where prohibited by law, taxed, or restricted. Amount of rebate not to exceed $35 or co-pay, whichever is less. This certificate may not be reproduced and must accompany your request for a rebate. Offer good for prescription of VANIQA® (eflornithine HCl) Cream, 13.9%, lawfully purchased from an authorized retailer or distributor in the United States. Allergan reserves the right to rescind, revoke, and amend this offer without notice. You are responsible for reporting receipt of a rebate to any private insurer that pays for, or reimburses you, for any part of the prescription filled, using this certificate.